Insights from 2023 ASCO® Annual Meeting

 

Lung
17:57

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options for Surgically Resectable NSCLC Patients"

FEATURING David Carbone, Brendon Stiles
  • 719 views
  • July 21, 2023
  • 7
05:10

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "LUNAR Trial Key Learnings & Clinical Implications - TTF Therapy for mNSCLC After Platinum Failure"

FEATURING Jack West
  • 39 views
  • July 10, 2023
07:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Implications - Pembro + Chemo Followed by Resection and Adjuvant Pembro for Early NSCLC"

FEATURING Jack West
  • 955 views
  • July 10, 2023
  • 5
04:46

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 LATIFY Study - Ceralasertib + Durvalumab vs. Docetaxel in Patients With Locally Advanced or Metastatic NSCLC That Progressed on or After Anti-PD-(L)1 & Platinum-Based Therapy"

FEATURING Benjamin Besse
  • 126 views
  • July 9, 2023
  • 1
21:44

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Resection of Localized Lung Cancer"

FEATURING Jessica Donington
  • 138 views
  • July 9, 2023
  • 1
05:13

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 LAGOON Study - Lurbinectedin Alone or in Combination With Irinotecan vs. Investigator's Choice (Topotecan/Irinotecan) for Relapsed SCLC"

FEATURING Benjamin Besse
  • 138 views
  • July 9, 2023
13:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib as Tissue-Agnostic Therapy for BRAFV600E+ Adult & Pediatric Solid Tumors"

FEATURING Vivek Subbiah
  • 1,214 views
  • July 6, 2023
  • 3
13:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1929 Phase II Randomized Study - Maintenance Atezo vs. Atezo + Talazoparib in Patients With SLFN11+ ES-SCLC"

FEATURING Nagla Abdel Karim
  • 46 views
  • July 3, 2023
  • 1
06:25

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial and Systemic Efficacy of Repotrectinib in Advanced ROS1+ NSCLC & CNS Mets"

FEATURING Jessica Lin
  • 76 views
  • July 2, 2023
  • 1
09:10

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 3 DeLLphi-304 Study - Tarlatamab, a DLL3-Targeting BiTE, Compared to Standard of Care in Patients With Relapsed SCLC"

FEATURING Luis Paz-Ares
  • 152 views
  • July 2, 2023
  • 1
11:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implications for Advanced NSCLC"

FEATURING Jack West
  • 2,227 views
  • June 21, 2023
  • 11
09:45

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ctDNA Dynamics & Survival Outcomes in Pts with aNSCLC and High (>50%) PD-L1 Expression Randomized to Cemiplimab vs. Chemo"

FEATURING Natalie Vokes
  • 134 views
  • June 21, 2023
  • 4
14:40

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 KEYNOTE-789 Study - Pemetrexed & Platinum +/- Pembro for TKI-Resistant, EGFRm, Metastatic Non-Squamous NSCLC"

FEATURING James Yang
  • 236 views
  • June 15, 2023
  • 2
08:43

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III, Double-Blinded, Randomized, Active-Controlled Study on the Efficacy & Safety of QL1706 + Chemo as 1L Therapy for PD-L1- Advanced or Metastatic NSCLC"

FEATURING Li Zhang
  • 95 views
  • June 15, 2023
06:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Primary Endpoint Analysis of the Phase II SCARLET Study - Sotorasib + Carboplatin-Pemetrexed in Pts With Advanced Non-Squamous NSCLC With KRAS G12C Mutation"

FEATURING Hiroaki Akamatsu
  • 241 views
  • June 15, 2023
  • 1
20:30

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "New Therapies for SCLC"

FEATURING Sally C. M. Lau
  • 288 views
  • June 15, 2023
  • 1
06:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "3-Year Results of the IFCT-1701 DICIPLE Phase 3 Trial - Nivo + Ipi 6-Month Treatment vs. Continuation in Advanced NSCLC"

FEATURING Anne-Claire Toffart
  • 490 views
  • June 12, 2023
08:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ARC-7: Randomized Phase 2 Study of Domvanalimab + Zimberelimab ± Etrumadenant vs. Zimberelimab in 1L PD-L1-High mNSCLC"

FEATURING Melissa Johnson
  • 821 views
  • June 9, 2023
  • 5
04:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Survival Data From a Randomized Phase 2 Trial Comparing High-Dose With Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited Stage SCLC"

FEATURING Bjørn Henning Grønberg
  • 74 views
  • June 9, 2023
08:53

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "CASPIAN Study Phase 3 Updates: The Prognostic Value of PROs and Clinical/Demographic Variables in ES-SCLC"

FEATURING Aparkishor Ganti
  • 232 views
  • June 6, 2023
  • 1
08:55

Insights from 2023 ASCO® Annual Meeting

Surgical Aspects in the Treatment of Locally Advanced NSCLC

FEATURING Giulia Veronesi
  • 465 views
  • June 5, 2023
  • 2